Hjem › Lupus
Lupus kliniske forsøg rekrutterer i USA
73 studier for Lupus rekrutterer deltagere på steder over hele USA.
Byer med flest studier
- New York City, NY18 studier
- Houston, TX13 studier
- Durham, NC12 studier
- Washington, DC10 studier
- Miami, FL10 studier
- Tampa, FL9 studier
- Philadelphia, PA9 studier
- Clearwater, FL8 studier
- Santa Monica, CA8 studier
- Oklahoma City, OK8 studier
- Los Angeles, CA8 studier
- Boston, MA8 studier
- Chicago, IL8 studier
- Memphis, TN7 studier
- Buena Park, CA7 studier
- San Diego, CA7 studier
- Charlotte, NC7 studier
- Plantation, FL7 studier
- Hollywood, FL6 studier
- Aurora, CO6 studier
- Dallas, TX6 studier
- Cedar Rapids, IA6 studier
- Atlanta, GA6 studier
- Cicero, IL5 studier
- Lake Charles, LA5 studier
- Cleveland, OH5 studier
- New Orleans, LA5 studier
- Fullerton, CA5 studier
- Jackson, TN5 studier
- St. Louis, MO5 studier
- Orlando, FL5 studier
- Syracuse, NY5 studier
- Coral Springs, FL4 studier
- Rochester, NY4 studier
- Allen, TX4 studier
- Arlington, TX4 studier
- Flint, MI4 studier
- Louisville, KY4 studier
- Phoenix, AZ4 studier
- Brandon, FL4 studier
Efter delstat
- Alabama5 studier
- Arizona7 studier
- Californien27 studier
- Colorado8 studier
- District of Columbia5 studier
- Florida23 studier
- Georgia9 studier
- Illinois14 studier
- Indiana4 studier
- Iowa6 studier
- Kansas5 studier
- Kentucky4 studier
- Louisiana9 studier
- Maryland10 studier
- Massachusetts9 studier
- Michigan10 studier
- Minnesota5 studier
- Missouri8 studier
- Nebraska3 studier
- New Jersey6 studier
- New York26 studier
- North Carolina20 studier
- Ohio11 studier
- Oklahoma8 studier
- Pennsylvania14 studier
- South Carolina5 studier
- Tennessee13 studier
- Texas26 studier
- Utah4 studier
- Virginia3 studier
- Washington5 studier
Nyligt opdaterede studier
Officiel studietekst (engelsk)
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
RekruttererFase 3
Alder 16 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT06617325Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
RekruttererFase 2
Alder 18 til 100 · Alle køn · Opdateret 1. okt. 2026 · NCT05268289A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
RekruttererFase 2
Alder 18 til 74 · Alle køn · Opdateret 1. okt. 2026 · NCT07409181Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
RekruttererFase 3
Alder 12 til 100 · Alle køn · Opdateret 1. okt. 2026 · NCT06133972An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
RekruttererFase 3
Alder 5 til 17 · Alle køn · Opdateret 30. sep. 2026 · NCT05835310Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in SLE Subjects Receiving Cyclophosphamide as Determined by Questionnaires
RekruttererObservationsstudie
Alder 18 til 120 · Kvinder · Opdateret 28. sep. 2026 · NCT05567198A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
RekruttererFase 3
Alder 18 til 70 · Alle køn · Opdateret 25. sep. 2026 · NCT07430306A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
RekruttererFase 3
Alder 18 til 75 · Alle køn · Opdateret 25. sep. 2026 · NCT07438496A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)
RekruttererFase 1
Alder 18 til 75 · Alle køn · Opdateret 25. sep. 2026 · NCT07607964CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus
RekruttererFase 1/2
Alder 10 til 29 · Alle køn · Opdateret 24. sep. 2026 · NCT06839976Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 23. sep. 2026 · NCT03816345Anifrolumab Pregnancy Study
RekruttererObservationsstudie
Alder 18 til 130 · Kvinder · Opdateret 18. sep. 2026 · NCT07049653The Role of Anifrolumab in Improving Markers of Vascular Risk in Patients With Systemic Lupus Erythematosus (SLE) - IFN-CVD
RekruttererFase 2
Alder 18 til 80 · Alle køn · Opdateret 18. sep. 2026 · NCT05440422Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants
RekruttererFase 1
Alder 18 til 65 · Alle køn · Opdateret 18. sep. 2026 · NCT07201558A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or Without Lupus Nephritis
RekruttererFase 2
Alder 16 til 70 · Alle køn · Opdateret 17. sep. 2026 · NCT07328581Transcutaneous Vagus Nerve Stimulation in SLE
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 17. sep. 2026 · NCT06987565Study of Systemic Lupus Erythematosus
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 3 til 120 · Alle køn · Opdateret 16. sep. 2026 · NCT00001372HEALTH Home Urinalysis Testing
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 16. sep. 2026 · NCT07823478Prospective Registry Investigating Maternal, Infant, and Lactation Outcomes in Anifrolumab Users
RekruttererFase 4
Alder 18 til 130 · Kvinder · Opdateret 16. sep. 2026 · NCT06594068A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
RekruttererFase 1
Alder 18 til 70 · Alle køn · Opdateret 15. sep. 2026 · NCT06916806Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis
RekruttererFase 1
Alder 18 til 60 · Alle køn · Opdateret 14. sep. 2026 · NCT06975787A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)
RekruttererFase 3
Alder 18 til 75 · Alle køn · Opdateret 14. sep. 2026 · NCT07355218A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis
RekruttererFase 2
Alder 12 til 70 · Alle køn · Opdateret 14. sep. 2026 · NCT07570862A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease
RekruttererFase 3
Alder 18 til 75 · Alle køn · Opdateret 11. sep. 2026 · NCT07332481A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE
RekruttererFase 1/2
Alder 18 til 70 · Alle køn · Opdateret 10. sep. 2026 · NCT06897930Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.